This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
|Yesterday’s UK 100 Leaders||Price (p)||% Chg|
|OCADO GROUP PLC||855.4||4.3%|
|HIKMA PHARMACEUTICALS PLC||1,546.5||2.9%|
|BT GROUP PLC||185.2||2.0%|
|LONDON STOCK EXCHANGE GROUP||7,464.0||1.7%|
|BURBERRY GROUP PLC||1,633.0||1.7%|
|Yesterday’s UK 100 Laggards||Price (p)||% Chg|
|ROLLS-ROYCE HOLDINGS PLC||81.9||-5.0%|
|PERSHING SQUARE HOLDINGS LTD||2360.0||-4.7%|
|ANGLO AMERICAN PLC||3061.0||-4.6%|
|Major World Indices||Price||% Chg||1 YEAR|
|UK 100 INDEX||7,020||-1.0%||-0.8%|
|DOW JONES INDUS. AVG||30,663||0.6%||-9.5%|
|S&P/ASX 200 INDEX||6,528||0.3%||-10.3%|
|WTI Crude Oil (Nymex)||USD/bbl.||104.41||-1.68%|
|Brent Crude (ICE)||USD/bbl.||110.17||-1.40%|
|Gold Spot||USD/t oz.||1,827||-0.6%|
The UK 100 is called to open +65 points this morning at 7065. The UK 100 looks set once again to bounce this morning, investors seem unperturbed after night of disastrous by-election results for the government, this led to the chair of the Conservative Party, Oliver Dowden, resigning. In the US yesterday, the Dow surged 194 points to close at 30,677 while the S&P 500 leapt 36 points to 3,796. The happy mood has continued in Asia this morning with Japan’s Nikkei 225 up 272 points to 26,444 and Hong Kong’s Hang Seng 309 points firmer at 21,583.
Barclays buys Kensington Mortgage company for around £2.3bn.
Essentra sells packaging business to Mayr-Melnhof for £312m.
GlaxoSmithKline & Sanofi announce positive data from Omicron COVID vaccine.
RPS Group says trading in the 5 months ended May 27th was encouraging and ahead of expectations.
No new broker comments
EU leaders summit
UK Retail Sales
German IFO – Business Climate
US Michigan Consumer Sentiment Index
US New Home Sales
B&M European Value Retail S.A.
Tate & Lyle
F&C Investment Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.